Replies to post #386954 on Elite Pharmaceuticals Inc (ELTP)

[imanjen13]

Both Oxycontin and Concerta are Schedule II drugs with a quota assigned by the DEA. Considering the recent success Kirkov and Nasrat have achieved with Adderall, it is reasonable to assume that the quota may start off at a modest 2-5% and then increase as the company shows it is a reliable manufacturer and distributor of the products.

If either of these 2 future needle movers are approved, a 1$ Nasdaq qualifying price is not out of the question.

[The ELTP King]

You could just read my iBox to see how many competitors there are for Concerta.

Good grief...

Concerta could have only a few comps.